Here come Medicare’s first negotiated drug prices

You’re reading the web edition of D.C. Diagnosis, STAT’s twice-weekly newsletter about the politics and policy of health and medicine. Sign up here to receive it in your inbox on Tuesdays and Thursdays.

BIO’s John Crowley on China, Trump, and vaccines

Former biotech CEO John Crowley is bringing big changes to the biotech industry’s largest lobbying group. He’s a Republican who wants to keep the organization focused on its core mission instead of on social issues. He restructured the organization to dedicate more resources to vaccine education and women’s health, since becoming BIO’s CEO in March.

Crowley sat down with me and my colleague John Wilkerson for a wide-ranging conversation about his interest (or lack thereof) in serving in a Trump administration, his views on the GOP’s stance on vaccines, the group’s position on the BIOSECURE Act, and his strategy in implementing layoffs earlier this year.

STAT+ Exclusive Story

Already have an account? Log in

This article is exclusive to STAT+ subscribers

Unlock this article — plus in-depth analysis, newsletters, premium events, and networking platform access.

Already have an account? Log in

Already have an account? Log in

Individual plans

Group plans

Monthly

$39

Totals $468 per year

$39/month Get Started

Totals $468 per year

Starter

$30

for 3 months, then $39/month

$30 for 3 months Get Started

Then $39/month

Annual

$399

Save 15%

$399/year Get Started

Save 15%

11+ Users

Custom

Savings start at 25%!

Request A Quote Request A Quote

Savings start at 25%!

2-10 Users

$300

Annually per user

$300/year Get Started

$300 Annually per user

View All Plans

Get unlimited access to award-winning journalism and exclusive events.

Subscribe

Log In